GALIMEDIX THERAPEUTICS
Galimedix Therapeutics is an ophthalmic pharmaceutical company that develops novel and transformative treatments.
GALIMEDIX THERAPEUTICS
Industry:
Pharmaceutical Therapeutics
Address:
Kensington, Maryland, United States
Country:
United States
Website Url:
http://www.galimedix.com
Total Employee:
1+
Status:
Active
Contact:
972-4-9905139
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Official Site Inspections
http://www.galimedix.com
- Host name: mi3-ts107.a2hosting.com
- IP address: 66.198.240.20
- Location: Ann Arbor United States
- Latitude: 42.2503
- Longitude: -83.8393
- Metro Code: 505
- Timezone: America/Detroit
- Postal: 48106
More informations about "Galimedix Therapeutics"
Galimedix Therapeutics
At Galimedix, we are working to improve the lives of millions of patients worldwide by โฆSee details»
About us โ Galimedix Therapeutics
Galimedix is a Phase 2 clinical-stage company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious eye and brain diseases. Founded by a seasoned and highly dedicated โฆSee details»
Galimedix Therapeutics - Crunchbase Company Profile & Funding
Galimedix Therapeutics is located in Kensington, Maryland, United States. Who invested in โฆSee details»
Galimedix Therapeutics, Inc. | LinkedIn
Galimedix Therapeutics is a Phase 2 neuropharmaceutical company developing novel first-in-class drugs with ground-breaking potential to slow or stop the progression of neurodegeneration and to ...See details»
Galimedix Therapeutics GmbH - Innovations- und Gründerzentrum ...
Galimedix is a Phase 2 clinical-stage private company developing novel oral and topical โฆSee details»
Partnering โ Galimedix Therapeutics
Licensing agreement with TOI โ an important first development and commercialization โฆSee details»
Galimedix Therapeutics - PitchBook
Galimedix Therapeutics is headquartered in Kensington, MD. What is the size of Galimedix โฆSee details»
Galimedix Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Galimedix โฆSee details»
Galimedix - Products, Competitors, Financials, Employees, โฆ
Galimedix operates as an ophthalmic pharmaceutical company. It develops novel and โฆSee details»
Galimedix Therapeutics - VentureRadar
Galimedix is a clinical stage pharmaceutical and ophthalmic company developing โฆSee details»
Galimedix Therapeutics GmbH - Innovations- und โฆ
Galimedix verfolgt das Ziel, neurodegenerative Prozesse an ihrem Ursprung zu stoppen und entwickelt bahnbrechende neuroprotektive Therapien zur Behandlung schwerer Augen- und Hirnerkrankungen, an denen Millionen โฆSee details»
Galimedix Therapeutics, Inc. - GoingPublic.de
Galimedix is a Phase 2 clinical-stage private biotechnology company developing novel oral and โฆSee details»
Théa and Galimedix enter into Licensing Agreement | Théa
Galimedix will grant TOI exclusive rights for the development and commercialization of GAL โฆSee details»
Galimedix Therapeutics - Overview, News & Similar companies
Jun 15, 2021 Galimedix Therapeutics is a Phase 2 neuropharmaceutical company developing โฆSee details»
Galimedix Therapeutics, Inc. | Insights
Apr 7, 2023 Galimedix; See more in Biomedtracker. Latest on Galimedix Therapeutics, Inc. โฆSee details»
Our science โ Galimedix Therapeutics
Galimedix is developing cutting-edge orally and topically administered Aฮฒ aggregation โฆSee details»
BIO-Europe: Galimedix is developing amyloid beta aggregation โฆ
Nov 5, 2024 BIO-Europe: Galimedix is developing amyloid beta aggregation modulators to try โฆSee details»
News โ Galimedix Therapeutics
Mar 8, 2024 Galimedix is proud to report that the inventor of the companyโs groundbreaking โฆSee details»
Galimedix Accelerating Development of Its Next-Generation Oral โฆ
Jun 15, 2021 Galimedix's clinical R&D program is designed to leverage this sustained efficacy โฆSee details»
Our Pipeline โ Galimedix Therapeutics
Galimedix is developing amyloid beta (Aฮฒ) aggregation modulators as oral and topical drugs for โฆSee details»